Top Markets
Coin of the day
SpectraScience, Inc. SpectraScience, Inc.

SpectraScience, Inc.

SCIE
Rangering i aksjer #42097
SpectraScience, Inc. specializes in creating and distributing an advanced... SpectraScience, Inc. specializes in creating and distributing an advanced technological platform designed for the immediate classification of tissue as normal, pre-cancerous, or cancerous, thereby bypassing the requirement for invasive physical biopsies. This innovative approach is accessible in the United States, Europe, and other global regions. The company's product line includes the WavSTAT3 optical biopsy system, which assesses colon tissue for normal, pre-cancerous, or cancerous conditions without surgical removal. Another key offering is the WavSTAT4 optical biopsy system, a diagnostic tool for the colon that employs UV laser light to optically scan and analyze tissue, enabling physicians to make instant diagnoses during endoscopic cancer screenings. Additionally, SpectraScience provides related accessories such as mobile consoles and disposable forceps. The company is also actively developing an application for esophageal diagnostics, focused on identifying pre-cancerous and cancerous tissue formations. Founded in 1983, the company operated as GV Medical, Inc. until it adopted the name SpectraScience, Inc. in October 1992, and is headquartered in San Diego, California.
Aksjekurs
$0.000001
Sist synkronisert: 2025-08-26
Markedsverdi
$4.92K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel SpectraScience, Inc. (SCIE)

Kategori

P/S-forhold for SpectraScience, Inc. (SCIE)
P/S-forhold per 2026 TTM: 0
Ifølge SpectraScience, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for SpectraScience, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter